Pages that link to "Q40741169"
Jump to navigation
Jump to search
The following pages link to A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila (Q40741169):
Displaying 50 items.
- The P42 peptide and Peptide-based therapies for Huntington's disease (Q26764930) (← links)
- The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model (Q27644551) (← links)
- Huntingtin aggregation and toxicity in Huntington's disease (Q28204163) (← links)
- Concentration-dependent, size-independent toxicity of citrate capped AuNPs in Drosophila melanogaster (Q28478708) (← links)
- Epidermolysis bullosa simplex-type mutations alter the dynamics of the keratin cytoskeleton and reveal a contribution of actin to the transport of keratin subunits. (Q30539002) (← links)
- An engineered viral protease exhibiting substrate specificity for a polyglutamine stretch prevents polyglutamine-induced neuronal cell death (Q31028322) (← links)
- A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo (Q33756277) (← links)
- Drosophila models of neurodegenerative disease (Q33844727) (← links)
- Decreased neuronal bursting and phase synchrony in the hippocampus of streptozotocin diabetic rats (Q33908628) (← links)
- Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies. (Q33914222) (← links)
- An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors (Q34066654) (← links)
- Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis (Q34079770) (← links)
- Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity (Q34431070) (← links)
- Polyglutamine fibrillogenesis: the pathway unfolds (Q34466014) (← links)
- Fighting anthrax with flies (Q34480470) (← links)
- POTENTIAL APPLICATION OF GRAPE DERIVED POLYPHENOLS IN HUNTINGTON'S DISEASE (Q34576042) (← links)
- The spinocerebellar ataxias: order emerges from chaos (Q34778116) (← links)
- Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine (Q34805750) (← links)
- A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila (Q35022497) (← links)
- Dying for a cause: invertebrate genetics takes on human neurodegeneration (Q35074847) (← links)
- Are Huntington's and polyglutamine-based ataxias proteasome storage diseases? (Q35097613) (← links)
- Invertebrate models of neurologic disease: insights into pathogenesis and therapy (Q35197814) (← links)
- Oxidative Stress in Neurodegeneration (Q35224677) (← links)
- Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease. (Q35239346) (← links)
- Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future (Q35589292) (← links)
- Structural Insights Reveal the Dynamics of the Repeating r(CAG) Transcript Found in Huntington's Disease (HD) and Spinocerebellar Ataxias (SCAs) (Q35684183) (← links)
- The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases (Q35708355) (← links)
- Experimental therapeutics in transgenic mouse models of Huntington's disease (Q35752429) (← links)
- Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein (Q35965543) (← links)
- blue cheese mutations define a novel, conserved gene involved in progressive neural degeneration. (Q35989365) (← links)
- A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules (Q36067065) (← links)
- Novel therapeutic targets for Huntington's disease. (Q36219680) (← links)
- Therapeutics development for triplet repeat expansion diseases (Q36277195) (← links)
- The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model (Q36370547) (← links)
- Hypothesis: Huntingtin may function in membrane association and vesicular trafficking (Q36704515) (← links)
- Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. (Q36854847) (← links)
- Neurobiological applications of small molecule screening (Q37151213) (← links)
- Contribution of Neuroepigenetics to Huntington's Disease. (Q37611722) (← links)
- Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease (Q37776087) (← links)
- Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models. (Q37832902) (← links)
- What have we learned from gene expression profiles in Huntington's disease? (Q37912519) (← links)
- Choosing an animal model for the study of Huntington's disease (Q38139868) (← links)
- Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease (Q38345839) (← links)
- Studying polyglutamine diseases in Drosophila. (Q38563516) (← links)
- Long Term Aggresome Accumulation Leads to DNA Damage, p53-dependent Cell Cycle Arrest, and Steric Interference in Mitosis. (Q38832369) (← links)
- Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila (Q40231204) (← links)
- Modified single-stranded oligonucleotides inhibit aggregate formation and toxicity induced by expanded polyglutamine (Q40509235) (← links)
- The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue? (Q41862238) (← links)
- A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases. (Q42121340) (← links)
- Optimization of trans-Splicing for Huntington's Disease RNA Therapy (Q42654161) (← links)